Detalhe da pesquisa
1.
Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis-Findings From the REAL Study.
J Clin Rheumatol
; 28(4): 206-211, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319537
2.
Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort.
Adv Rheumatol
; 64(1): 23, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553751
3.
Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.
Clin Rheumatol
; 42(5): 1249-1258, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715850
4.
Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study.
Adv Rheumatol
; 63(1): 3, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747307
5.
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort.
Adv Rheumatol
; 63(1): 34, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496102
6.
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.
Adv Rheumatol
; 63(1): 17, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095556
7.
Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
PLoS One
; 17(9): e0273789, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174077
8.
Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial.
Adv Rheumatol
; 61(1): 7, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468249
9.
Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis.
Int J Clin Pharm
; 43(3): 737-742, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085040
10.
Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.
Adv Rheumatol
; 61(1): 38, 2021 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172097
11.
Real - rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil.
Adv Rheumatol
; 60(1): 20, 2020 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171331
12.
Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study.
Adv Rheumatol
; 60(1): 16, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106881
13.
Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
PLoS One
; 15(3): e0230317, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168350
14.
Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
PLoS One
; 14(4): e0215198, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30947308
15.
Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
PLoS One
; 14(3): e0213219, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30822348
16.
The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.
Adv Rheumatol
; 58(1): 9, 2018 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657089
17.
Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort
Adv Rheumatol
; 63: 34, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1505590
18.
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study
Adv Rheumatol
; 63: 17, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1447135
19.
Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study
Adv Rheumatol
; 63: 3, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1447136
20.
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies.
Reumatol Clin
; 13(4): 201-209, 2017.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27317492